Drug intelligence / Profile preview

Rovidium

Development stage
Unknown
Lead developer
SanuLife
Modality
Small Molecules
Administration
Oral
01

Overview

ROVIDIUM is a dietary supplement product series developed by SanuLife, designed to address both aging and cancer. The name is an acronym for 'RhoB inducer' (RO for RhoB tumor suppressor gene, VI for revival, and DIUM for matrix). It is a small molecule formulation containing high-purity active ingredients, including rice germ and rice bran extract (Ceramide), turmeric extract (Curcumin), and green tea extract (epigallocatechin gallate, or EGCG). The product works by harnessing the tumor suppressor gene RhoB and endogenous longevity transcriptional factors to protect normal cells while targeting cancer cells. ROVIDIUM is produced in California according to cGMP standards and was launched in the United States in August 2018. The ingredients are classified by the US FDA as 'Generally Recognized as Safe' (GRAS). It is available in both core and luxury versions, with the luxury version containing additional components such as Coenzyme Q10 (CoQ10), Pyrroloquinoline quinone (PQQ), and B vitamins.

Brand names
Rovidium
02

Targets

RHOB (Ras homolog family member B)

Beyond the preview

Go deeper on Rovidium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rovidium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call